vizoya bpc-157 Healthgevity BPC-157 + KPV + P – TrustScore® 8.3/10 BPC-157 - Vitality Research

Patients were randomized (n=456) to receive pemetrexed 500 mg/m2 intravenously over 10 minutes followed 30 minutes later by cisplatin 75 mg/m2 intravenously over two hours on Day 1 of each 21-day cycle or to receive cisplatin 75 mg/m2 intravenously over 2 hours on Day 1 of each 21-day cycle

1978 Feb;31(2):253-8

BPC-157 increases blood flow to damaged areas, stabilizes nitric oxide production, and promotes collagen formation

A vitamin C injection requires Ascorbic acid in liquid form, a needle and a syringe

Exclusively breastfed infants of mothers who are vegan, vegetarian, or B12 deficient need careful monitoring [*]

If the levels are below 150mg/Dl, the risk increases by 5 percent